Edition:
United Kingdom

Strongbridge Biopharma plc (SBBP.OQ)

SBBP.OQ on NASDAQ Stock Exchange Global Select Market

6.20USD
3:01pm GMT
Change (% chg)

$-0.15 (-2.36%)
Prev Close
$6.35
Open
$6.30
Day's High
$6.40
Day's Low
$6.20
Volume
2,228
Avg. Vol
40,509
52-wk High
$8.20
52-wk Low
$2.05

Latest Key Developments (Source: Significant Developments)

Strongbridge Biopharma Q3 loss per share $0.98
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Strongbridge Biopharma Plc :Strongbridge Biopharma Plc provides corporate update and reports third quarter 2017 financial results.Q3 non-GAAP loss per share $0.35.Q3 GAAP loss per share $0.98.Q3 earnings per share view $-0.38 -- Thomson Reuters I/B/E/S.Strongbridge Biopharma Plc- ‍Recorlev (levoketoconazole) phase 3 top-line results remain on track with SONICS in Q2 2018 and LOGICS in Q4 2018​.Strongbridge Biopharma Plc- existing cash resources at Sept 30, net proceeds from Oct offering provides sufficient cash under current operating plan​.Strongbridge Biopharma Plc- ‍had pro forma cash and cash equivalents of $67.8 million as of September 30, 2017​.Strongbridge Biopharma Plc - qtrly total revenues $‍2.5 million​.  Full Article

Storebrand Asset Management reports 5.01 pct passive stake in Strongbridge Biopharma
Thursday, 29 Sep 2016 

Storebrand Asset Management:Storebrand Asset Management AS reports 5.01 pct passive stake in Strongbridge Biopharma Plc as of Sept 20 - SEC filing.  Full Article

Strongbridge Biopharma reports Q1 loss per share $0.57
Tuesday, 17 May 2016 

Strongbridge Biopharma PLC : Strongbridge Biopharma PLC reports first quarter 2016 financial results . Company believes it has sufficient existing cash and cash equivalents to fund planned operations into Q4 of 2017 . Q1 loss per share $0.57 .Q1 earnings per share view $-0.60 -- Thomson Reuters I/B/E/S.  Full Article

BRIEF-Strongbridge Biopharma Q3 loss per share $0.98

* Strongbridge Biopharma Plc provides corporate update and reports third quarter 2017 financial results